
Sunicine 25mg Capsule
Salt Composition: Sunitinib
Expiry Date: 01/2028
Inclusive of all taxes
28 Capsules in Bottle
About The Product
Kidney Cancer, Gastrointestinal stromal tumors
Sunicine 25mg capsule is a prescription-based anticancer drug. It is used in the treatment of Kidney cancer and Gastrointestinal stromal tumors. This anticancer medicine reduces the size of the tumor and slows down the multiplication rate of cancer cells. It may take multiple weeks or several months to observe the benefits, so do not stop taking it until your doctor asks you to do so.
Uses
- Kidney cancer
- Gastrointestinal stromal tumor
Side Effects
Sunicine 25mg capsule shows some side effects. Some of the mild ones do not need any medical attention, and they go away as the body adapts to the medicine. It is important to consult your doctor if they persist for a longer time and are deteriorating your health:
Common side effects include:
- Nausea
- Insomnia
- Difficulty in breathing
- Bleeding
- Vomiting
- Abdominal pain
- Hair loss
- Weakness
- Rash
- Fatigue
- Cough
- Diarrhea
- Constipation
- Decreased appetite
- Inform your doctor immediately if you experience any persistent or unusual side effects.
How To Use
- Sunicine 25mg Capsule is a prescription-based anticancer drug that should be administered orally.
- Take it in doses and duration advised by the doctor.
- This capsule may be taken with or without food at a fixed time every day to get effective results.
- Don't chew or break the capsule.
- Don't miss a dose or overdose on the medicine.
How It Works
Sunicine 25mg capsule is a medication used to prevent the growth of cancer cells. It works by binding and blocking specific kinds of cell surface proteins (tyrosine kinases).
This protein is responsible for the growth of cancer cells in the human body. Sunicine capsule also prevents the formation of new blood vessels within the tumor.
In this way, it prevents the multiplication of malignant cancers.
Safety Advice
Missed Doses
- It is advised not to miss any scheduled dosage of Sunicine 25mg Capsule.
- In case you miss a dose, consult your doctor immediately.
- Don't overdose to compensate for the missed one.
- Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.
Quick Tips
Keep your body hydrated by drinking plenty of fluids to avoid dehydration as Diarrhea may occur as one of the side effects of Sunicine 25mg Capsule. Inform your doctor immediately in case of blood in stools.
Sunicine 25mg Capsule may slow down the wound healing time. It is advised to carefully perform activities like shaving, cutting fingernails or toenails, or using sharp objects.
It is important to monitor the blood pressure regularly after taking Sunicine 25mg Capsule. Some fluctuations may be observed after undergoing treatment with this medicine.
Consult your doctor if you feel symptoms of high blood pressure like severe headache, confusion, eyesight problems, nausea, or vomiting.
FAQs
Take Sunicine 25mg Capsule in the exact way as prescribed by your doctor.
It is advised not to drink grapefruit juice or consume grapefruit during your treatment, as it may increase the chances of side effects.
Reference
- Gore, M. E., Hariharan, S., Porta, C., Bracarda, S., Hawkins, R., Bjarnason, G. A., ... & Szczylik, C. (2011). Sunitinib in metastatic renal cell carcinoma patients with brain metastases. Cancer, 117(3), 501-509 - https://pubmed.ncbi.nlm.nih.gov/20862748/
- Papaetis, G. S., & Syrigos, K. N. (2009). Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies. BioDrugs, 23(6), 377-389 - https://pubmed.ncbi.nlm.nih.gov/19894779/
- Sablin, M. P., Negrier, S., Ravaud, A., Oudard, S., Balleyguier, C., Gautier, J., ... & Escudier, B. (2009). Sequential sorafenib and sunitinib for renal cell carcinoma. The Journal of urology, 182(1), 29-34 - https://pubmed.ncbi.nlm.nih.gov/19447417/
- Hao, Z., & Sadek, I. (2016). Sunitinib: the antiangiogenic effects and beyond. OncoTargets and therapy, 5495-5505 - https://pmc.ncbi.nlm.nih.gov/articles/PMC5021055/
- Deeks, E. D., & Keating, G. M. (2006). Sunitinib. Drugs, 66(17), 2255-2266.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
